par Verschuere, Tina;De Vleeschouwer, Steven;Lefranc, Florence 
;Kiss, Robert ;Van Gool, Stefaan W
Référence Expert review of neurotherapeutics, 11, 4, page (533-543)
Publication Publié, 2011-04
;Kiss, Robert ;Van Gool, Stefaan WRéférence Expert review of neurotherapeutics, 11, 4, page (533-543)
Publication Publié, 2011-04
Article révisé par les pairs
| Titre: |
|
| Auteur: | Verschuere, Tina; De Vleeschouwer, Steven; Lefranc, Florence; Kiss, Robert; Van Gool, Stefaan W |
| Informations sur la publication: | Expert review of neurotherapeutics, 11, 4, page (533-543) |
| Statut de publication: | Publié, 2011-04 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | brain cancer |
| dendritic-cell mediated immunotherapy | |
| galectin-1 | |
| high-grade glioma | |
| immune privilege | |
| MeSH keywords: | Brain Neoplasms -- immunology -- pathology -- therapy |
| Cancer Vaccines -- immunology -- therapeutic use | |
| Combined Modality Therapy | |
| Dendritic Cells -- immunology | |
| Galectin 1 -- physiology | |
| Glioma -- immunology -- pathology -- therapy | |
| Humans | |
| Immunotherapy, Active | |
| Tumor Escape | |
| Note générale: | Journal Article |
| Research Support, Non-U.S. Gov't | |
| Review | |
| SCOPUS: re.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1473-7175 |
| info:doi/10.1586/ern.11.40 | |
| info:scp/79953757491 | |
| info:pmid/21469926 |
